Aduro Biotech, Inc

(NASDAQ:ADRO)

Latest On Aduro Biotech, Inc (ADRO):

Date/Time Type Description Signal Details
2020-10-07 21:30 ESTInsider TradeERIC DOBMEIER has directly acquired 46,337 shares and currently holds 46,337 shares.Buy
2020-10-07 21:30 ESTInsider TradeTom Frohlich has directly acquired 153,398 shares and currently holds 153,398 shares.Buy
2020-10-07 21:30 ESTInsider TradeDavis Jerel has indirectly acquired of 2,433,099 shares.Buy
2020-10-07 21:30 ESTInsider TradeDavis Jerel has indirectly acquired of 722,247 shares.Buy
2020-10-07 21:30 ESTInsider TradeDavis Jerel has indirectly acquired of 4,733,023 shares.Buy
2020-10-07 21:30 ESTInsider TradeDavis Jerel has directly acquired 730,470 shares and currently holds 730,470 shares.Buy
2020-10-07 21:30 ESTInsider TradeSRINIVAS AKKARAJU has indirectly acquired of 3,168,388 shares.Buy
2020-10-05 12:03 ESTAnalyst RatingThe Analyst Target Price has increased from $3.75 to $18.75.Buy
2020-10-03 16:01 ESTStock SplitA stock split has occured on Oct 2, 2020 with a split factor of 1:5.Neutral
2020-09-26 04:03 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 20:30 ESTInsider TradeCeleste Ferber has directly disposed of 2,396 shares and currently holds 38,687 shares.Sell
2020-09-17 20:30 ESTInsider TradeBlaine Templeman has directly disposed of 12,369 shares and currently holds 121,916 shares.Sell
2020-09-17 20:30 ESTInsider TradeSTEPHEN T ISAACS has directly disposed of 32,481 shares and currently holds 279,166 shares.Sell
2020-08-11 16:15 ESTInsider TradeCeleste Ferber has directly disposed of 7,951 shares and currently holds 41,083 shares.Sell
2020-08-11 16:15 ESTInsider TradeBlaine Templeman has directly disposed of 7,951 shares and currently holds 134,285 shares.Sell
2020-08-11 16:15 ESTInsider TradeDimitry SA Nuyten has directly disposed of 3,538 shares and currently holds 8,462 shares.Sell
2020-08-07 00:02 ESTFinancialsCompany financials have been released.Neutral
2020-08-04 06:02 ESTNewsAduro Biotech EPS misses by $0.02, beats on revenueN/A
2020-07-31 00:02 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 16:05 ESTFinancialsCompany financials have been released.Neutral
2020-06-25 04:17 ESTNewsDosing underway in Aduro Bio's BION-1301 study for kidney diseaseN/A
2020-06-04 08:02 ESTAnalyst RatingThe Analyst Target Price has decreased from $6.88 to $3.75.Neutral
2020-06-03 17:45 ESTInsider TradeBlaine Templeman has directly acquired 22,500 shares and currently holds 142,236 shares.Buy
2020-06-03 17:45 ESTInsider TradeDimitry SA Nuyten has directly acquired 10,000 shares and currently holds 12,000 shares.Buy
2020-06-03 17:45 ESTInsider TradeRoss Haghighat has directly acquired 34,124 shares and currently holds 121,246 shares.Buy
2020-06-03 17:45 ESTInsider TradeCeleste Ferber has directly acquired 22,500 shares and currently holds 49,034 shares.Buy
2020-06-03 17:45 ESTInsider TradeWilliam G Kachioff has directly acquired 10,000 shares and currently holds 10,000 shares.Buy
2020-06-03 08:02 ESTAnalyst RatingThe Analyst Target Price has decreased from $7 to $6.88.Neutral
2020-06-02 18:18 ESTNewsAduro Biotech and Chinook Therapeutics to mergeN/A
2020-06-02 08:02 ESTEarnings EstimateAn EPS average of -$0.18 is estimated for the quarter ending on September 30, 2020.Sell
2020-05-06 20:02 ESTFinancialsCompany financials have been released.Neutral
2020-05-05 00:11 ESTNewsAduro Biotech EPS beats by $0.05, beats on revenueN/A
2020-05-03 08:02 ESTFinancialsCompany financials have been released.Neutral
2020-04-10 16:01 ESTAnalyst RatingThe Analyst Target Price has decreased from $7.33 to $7.Neutral
2020-04-10 15:39 ESTNewsAduro Biotech EPS misses by $0.04, misses on revenueN/A
2020-04-09 00:01 ESTFinancialsCompany financials have been released.Neutral
2020-04-08 04:02 ESTFinancialsCompany financials have been released.Neutral
2020-04-08 00:02 ESTFinancialsCompany financials have been released.Neutral
2020-03-20 17:30 ESTInsider TradeSTEPHEN T ISAACS has directly disposed of 21,618 shares and currently holds 311,647 shares.Sell
2020-03-20 17:30 ESTInsider TradeWilliam Mariner Greenman has directly acquired 19,835 shares and currently holds 19,835 shares.Buy
2020-03-18 22:16 ESTNewsAduro: Float Like A Butterfly, Sting Like A BeeN/A
2020-03-12 04:01 ESTAnalyst RatingThe Analyst Target Price has increased from $7 to $7.33.Buy
2020-03-12 04:01 ESTFinancialsCompany financials have been released.Neutral
2020-03-10 04:01 ESTEarnings EstimateAn EPS average of -$0.62 is estimated for the 2021 year.Sell
2020-03-10 04:01 ESTEarnings EstimateAn EPS average of -$0.17 is estimated for the quarter ending on June 30, 2020.Buy
2020-02-27 19:01 ESTEarningsEarnings have been released on February 28, 2019, with -$0.33 earnings per share.Sell
2020-02-26 19:00 ESTInsider TradeElsas Andrea van has directly disposed of 6,823 shares and currently holds 438,367 shares.Sell
2020-02-10 03:01 ESTAnalyst RatingThe Analyst Target Price has increased from $6.75 to $7.Buy
2020-02-03 03:01 ESTAnalyst RatingThe Analyst Target Price has increased from $5.75 to $6.75.Buy
2020-01-28 07:02 ESTEarningsEarnings have been released on November 11, 2019, with -$0.26 earnings per share.Sell

About Aduro Biotech, Inc (ADRO):

Aduro Biotech, Inc., an immunotherapy company, focuses on the discovery, development, and commercialization of therapies to harness the body's natural immune system for the treatment of patients with challenging diseases. The company is developing ADU-S100, which is in Phase I dose escalation clinical trial and Phase Ib dose escalation clinical trial in combination with spartalizumab to treat patients with advanced, metastatic treatment-refractory solid tumors; Phase I clinical trial in combination with ipilimumab for the treatment of relapsed and refractory melanoma; and Phase II clinical trial in combination with pembrolizumab, an approved anti-PD-1 antibody in patients with squamous cell carcinoma of the head and neck. It is also developing product candidates to prevent or control immune responses through the stimulator of interferon genes pathway. In addition, the company is developing BION-1301, a fully blocking humanized monoclonal anti-APRIL antibody that is in Phase I clinical trial for IgA nephropathy; and CD27, a co-stimulatory receptor, which is in preclinical studies expressed on different immune cells, such as T-lymphocytes and natural killer cells. It has collaboration agreements with Novartis Pharmaceuticals Corporation, Eli Lilly and Company, and Merck Sharp and Dohme B.V.; and license agreements with Karagen Pharmaceuticals, Inc., UC Berkeley, and Memorial Sloan Kettering Cancer Center. The company was formerly known as Oncologic, Inc. and changed its name to Aduro Biotech, Inc. in June 2008. Aduro Biotech, Inc. was founded in 2000 and is headquartered in Berkeley, California.

See Advanced Chart

General

  • Name Aduro Biotech, Inc
  • Symbol ADRO
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 69
  • Last Split Factor1:5
  • Last Split Date2020-10-02
  • Fiscal Year EndDecember
  • IPO Date2015-04-15
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.aduro.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 7.01
  • Price/Book (Most Recent Quarter) 4.23
  • Enterprise Value Revenue 2.09
View More

Financials

  • Most Recent Quarter 2020-06-30
  • Current Year EPS Estimate -$2.70
  • Next Year EPS Estimate -$3.08
  • Profit Margin -231%
  • Operating Margin -240%
  • Return on Assets -14%
  • Return on Equity -87%
  • Revenue 27.96 million
  • Earnings Per Share -$1.15
  • Revenue Per Share $1.73
  • Gross Profit -48610000
  • Quarterly Earnings Growth 14%
View More

Highlights

  • Market Capitalization 236.61 million
  • EBITDA -87830000
  • PEG Ratio 0.06
  • Analyst Target Price $18.75
  • Book Value Per Share $2.88
View More

Share Statistics

  • Shares Outstanding 16.21 million
  • Shares Float 9.32 million
  • % Held by Insiders 2984%
  • % Held by Institutions 44.76%
  • Shares Short 3.21 million
  • Shares Short Prior Month 3.3 million
  • Short Ratio 4.66
  • Short % of Float 5%
  • Short % of Shares Outstanding 4%
View More

Technicals

  • Beta 0.39
  • 52 Week High $1185
  • 52 Week Low $0.9
  • 50 Day Moving Average 3.37
  • 200 Day Moving Average 2.88
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
View More

Aduro Biotech, Inc (ADRO) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Aduro Biotech, Inc (ADRO) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-06-302020-08-03$N/A-$1.05-$0.19-452.63%
2020-03-312020-05-04$N/A-$0.45-$0.13-246.15%
2019-12-312020-03-09$3.63 million-$1.20-$0.21-471.43%
2019-09-302019-11-07$4.8 million-$1.30-$0.23-465.22%
2019-06-302019-08-01$4.89 million-$1.15-$0.18-538.89%
2019-03-312019-05-07$3.94 million-$1.45-$0.19-663.16%
2018-12-312019-02-27$2.76 million-$0.33-$0.23-43.48%
2018-09-302018-10-30$3.06 million-$0.29-$0.316.45%
2018-06-302018-08-01$2.64 million-$0.31-$0.323.13%
2018-03-312018-05-02$6.63 million-$0.28-$0.3520%
2017-12-312018-03-01$3.76 million-$0.34-$0.365.56%
2017-09-302017-10-31$3.79 million-$0.33-$0.368.33%
2017-06-302017-08-02$5.92 million-$0.27-$0.270%
2017-03-312017-05-02$3.77 million-$0.32-$0.3917.95%
2016-12-312017-03-01$3.88 million-$0.44-$0.40-10%
2016-09-302016-11-02$3.79 million-$0.54-$0.47-14.89%
2016-06-302016-08-03$38.98 million$0.03-$0.06150%
2016-03-312016-05-02$4.03 million-$0.45-$0.25-80%
2015-12-312016-03-08$34.38 million$0.04-$0.15126.67%
2015-09-302015-11-24$19.15 million$0.01-$0.11109.09%
2015-06-302015-08-10$9.88 million-$0.50$0.57-187.72%
2015-03-312015-04-15$9.57 million-$39.97-$0.08-49862.5%

Aduro Biotech, Inc (ADRO) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019 Jun 30 2019
Research Development N/A 15.83 million N/A 15.51 million 16.88 million
Income Before Tax N/A N/A -19.51 million -23.2 million -18.61 million
Selling General Administrative N/A N/A 8.95 million 8.68 million 7.98 million
Gross Profit N/A N/A -12.67 million 4.8 million -10.81 million
Ebit N/A N/A -21.76 million -19.53 million -18.93 million
Operating Income N/A N/A -21.76 million -19.53 million -18.93 million
Income Tax Expense N/A -5.67 million -90000 -2.25 million -35000
Total Revenue N/A N/A 3.63 million 4.8 million 4.89 million
Cost of Revenue N/A N/A 16.31 million N/A 15.7 million
Total Other Income Expense Net N/A N/A 2.26 million -3.67 million 317000
Net Income From Continuing Operations N/A N/A -19.42 million -20.95 million -18.58 million
Net Income Applicable to Common Shares -16.62 million -7.58 million -19.42 million -20.95 million -18.58 million
Cash Flow:
Date Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019 Jun 30 2019
Investments N/A N/A 28.01 million -9.2 million -17.63 million
Change to Liabilities -4.23 million -2.2 million -4.5 million -3.95 million -4.14 million
Total Cash Flow from Investing Activities -2.66 million 42.6 million 27.94 million -10 million -17.59 million
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities N/A N/A 47000 93000 352000
Change to Operating Activities -3.74 million 2.89 million -1.46 million 1.14 million 1.56 million
Change in Cash N/A N/A 6.02 million -25.96 million -33.55 million
Total Cash from Operating Activities -20.96 million -7.87 million -22.07 million -15.85 million -16.38 million
Depreciation N/A N/A 1.19 million 1.22 million 1.23 million
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A -120000 1.14 million -656000
Other Cash Flow from Financing Activities N/A N/A N/A N/A N/A
Change to Net Income 2.75 million 4.26 million 2.23 million 5.54 million 4.21 million
Capital Expenditures N/A N/A 77000 801000 -42000
Balance Sheet:
Date Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019 Jun 30 2019
Total Liabailities N/A 225.91 million 225.72 million 231.27 million 236.94 million
Total Stockholder Equity N/A 59.58 million 65.6 million 82.05 million 101.05 million
Other Current Liabilities N/A N/A 7.72 million 16 million 17.41 million
Total Assets N/A N/A 291.31 million 313.31 million 337.99 million
Common Stock 8000 8000 8000 8000 8000
Other Current Assets N/A N/A N/A N/A 3.78 million
Retained Earnings -511.09 million -494.48 million -486.9 million -467.49 million -446.54 million
Other Liabilities 167.61 million 171.39 million 172.48 million 166.67 million 173.94 million
Other Assets 468000 468000 468000 468000 468000
Cash N/A N/A 59.62 million 53.61 million 79.56 million
Total Current Liabilities N/A N/A 21.6 million 32.48 million 30.41 million
Other Stockholder Equity 439000 -140000 414000 -178000 1.04 million
Property, Plant & Equipment 42.04 million 43.21 million 45.8 million 46.88 million 47.79 million
Total Current Assets N/A N/A 217.9 million 235.81 million 256.78 million
Long Term Investments N/A 3.01 million N/A 3.59 million N/A
Net Tangible Assets 19.72 million 33.09 million 38.45 million 55.49 million 68.09 million
Short Term Investments N/A 108.54 million 153.98 million 178.18 million 172.07 million
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable N/A 752000 414000 1.64 million 1000000

Aduro Biotech, Inc (ADRO) Chart:

Aduro Biotech, Inc (ADRO) News:

Below you will find a list of latest news for Aduro Biotech, Inc (ADRO) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Aduro Biotech, Inc (ADRO) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Aduro Biotech, Inc (ADRO) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-02425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1435049/000119312520186909/0001193125-20-186909-index.htm
2020-08-04UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1435049/000000000020007103/0000000000-20-007103-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1435049/000021545719006546/0000215457-19-006546-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1435049/000083423720004835/0000834237-20-004835-index.htm
2019-01-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1435049/000090221919000002/0000902219-19-000002-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1435049/000090221919000022/0000902219-19-000022-index.htm
2019-01-22SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1435049/000090445419000071/0000904454-19-000071-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1435049/000103738920000091/0001037389-20-000091-index.htm
2020-02-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1435049/000108887520000052/0001088875-20-000052-index.htm
2019-03-22SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1435049/000110465919016796/0001104659-19-016796-index.htm
2019-05-24SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1435049/000110465919031739/0001104659-19-031739-index.htm
2019-01-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1435049/000117031619000003/0001170316-19-000003-index.htm
2020-01-17SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1435049/000117031620000001/0001170316-20-000001-index.htm
2018-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000119312518289503/0001193125-18-289503-index.htm
2018-11-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000119312518323130/0001193125-18-323130-index.htm
2018-12-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000119312518352108/0001193125-18-352108-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000119312519003027/0001193125-19-003027-index.htm
2019-02-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1435049/000119312519032219/0001193125-19-032219-index.htm
2019-02-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000119312519046243/0001193125-19-046243-index.htm
2019-02-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1435049/000119312519054130/0001193125-19-054130-index.htm
2019-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1435049/000119312519054155/0001193125-19-054155-index.htm
2019-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000119312519188230/0001193125-19-188230-index.htm
2019-09-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000119312519257413/0001193125-19-257413-index.htm
2019-12-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000119312519316251/0001193125-19-316251-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000119312520004963/0001193125-20-004963-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000119312520005777/0001193125-20-005777-index.htm
2020-01-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000119312520013145/0001193125-20-013145-index.htm
2020-03-09S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1435049/000119312520067262/0001193125-20-067262-index.htm
2020-06-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000119312520157987/0001193125-20-157987-index.htm
2020-06-02425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1435049/000119312520157988/0001193125-20-157988-index.htm
2020-06-02425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1435049/000119312520158646/0001193125-20-158646-index.htm
2020-06-02425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1435049/000119312520158648/0001193125-20-158648-index.htm
2020-06-02425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1435049/000119312520158652/0001193125-20-158652-index.htm
2020-06-03425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1435049/000119312520158933/0001193125-20-158933-index.htm
2020-06-05425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1435049/000119312520160920/0001193125-20-160920-index.htm
2020-06-10425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1435049/000119312520165702/0001193125-20-165702-index.htm
2020-06-10425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1435049/000119312520165706/0001193125-20-165706-index.htm
2020-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000119312520186906/0001193125-20-186906-index.htm
2020-07-02425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1435049/000119312520186909/0001193125-20-186909-index.htm
2020-07-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000119312520194724/0001193125-20-194724-index.htm
2020-07-22S-4Registration of securities, business combinationshttps://www.sec.gov/Archives/edgar/data/1435049/000119312520196554/0001193125-20-196554-index.htm
2020-08-03425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1435049/000119312520208115/0001193125-20-208115-index.htm
2020-08-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000119312520223665/0001193125-20-223665-index.htm
2020-08-18425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1435049/000119312520223670/0001193125-20-223670-index.htm
2020-08-18425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1435049/000119312520223674/0001193125-20-223674-index.htm
2020-08-24S-4/ARegistration of securities, business combinationshttps://www.sec.gov/Archives/edgar/data/1435049/000119312520227443/0001193125-20-227443-index.htm
2020-08-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1435049/000119312520227456/0001193125-20-227456-index.htm
2020-08-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1435049/000119312520227491/0001193125-20-227491-index.htm
2020-08-26424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1435049/000119312520231238/0001193125-20-231238-index.htm
2020-08-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000119312520236282/0001193125-20-236282-index.htm
2020-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000119312520249542/0001193125-20-249542-index.htm
2020-09-21425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1435049/000119312520249551/0001193125-20-249551-index.htm
2020-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000119312520252523/0001193125-20-252523-index.htm
2020-09-24425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1435049/000119312520252525/0001193125-20-252525-index.htm
2020-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000119312520261293/0001193125-20-261293-index.htm
2020-10-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1435049/000119312520264856/0001193125-20-264856-index.htm
2020-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000119312520265606/0001193125-20-265606-index.htm
2020-10-15SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1435049/000119312520270350/0001193125-20-270350-index.htm
2020-11-058-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000119312520286962/0001193125-20-286962-index.htm
2020-10-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000120919120054231/0001209191-20-054231-index.htm
2020-10-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000120919120054232/0001209191-20-054232-index.htm
2020-10-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000120919120054233/0001209191-20-054233-index.htm
2020-10-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000120919120054234/0001209191-20-054234-index.htm
2020-10-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000120919120054236/0001209191-20-054236-index.htm
2020-10-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000120919120054237/0001209191-20-054237-index.htm
2020-10-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000120919120054238/0001209191-20-054238-index.htm
2020-10-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000120919120054241/0001209191-20-054241-index.htm
2020-10-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000120919120054242/0001209191-20-054242-index.htm
2020-10-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000120919120054244/0001209191-20-054244-index.htm
2020-10-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000120919120054245/0001209191-20-054245-index.htm
2020-10-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000120919120054246/0001209191-20-054246-index.htm
2020-10-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000120919120054247/0001209191-20-054247-index.htm
2020-10-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000120919120054248/0001209191-20-054248-index.htm
2020-10-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000120919120054249/0001209191-20-054249-index.htm
2020-10-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000120919120054250/0001209191-20-054250-index.htm
2020-10-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000120919120054251/0001209191-20-054251-index.htm
2020-10-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000120919120054252/0001209191-20-054252-index.htm
2020-10-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000120919120054253/0001209191-20-054253-index.htm
2020-06-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1435049/000121390020014723/0001213900-20-014723-index.htm
2019-03-298-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000155837019002631/0001558370-19-002631-index.htm
2019-03-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1435049/000155837019002636/0001558370-19-002636-index.htm
2019-03-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1435049/000155837019002638/0001558370-19-002638-index.htm
2019-04-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000155837019003083/0001558370-19-003083-index.htm
2019-04-18DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1435049/000155837019003085/0001558370-19-003085-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000155837019004266/0001558370-19-004266-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000155837019005082/0001558370-19-005082-index.htm
2018-10-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1435049/000156459018025616/0001564590-18-025616-index.htm
2018-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000156459018025624/0001564590-18-025624-index.htm
2019-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1435049/000156459019004942/0001564590-19-004942-index.htm
2019-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000156459019004945/0001564590-19-004945-index.htm
2019-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1435049/000156459019016502/0001564590-19-016502-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000156459019016517/0001564590-19-016517-index.htm
2019-08-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1435049/000156459019027956/0001564590-19-027956-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000156459019027964/0001564590-19-027964-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1435049/000156459019041741/0001564590-19-041741-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000156459019041752/0001564590-19-041752-index.htm
2020-03-0910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1435049/000156459020009364/0001564590-20-009364-index.htm
2020-03-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000156459020009368/0001564590-20-009368-index.htm
2020-03-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000156459020012521/0001564590-20-012521-index.htm
2020-03-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1435049/000156459020012526/0001564590-20-012526-index.htm
2020-03-24DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1435049/000156459020012532/0001564590-20-012532-index.htm
2020-04-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000156459020016116/0001564590-20-016116-index.htm
2020-05-0410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1435049/000156459020020832/0001564590-20-020832-index.htm
2020-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000156459020020835/0001564590-20-020835-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000156459020021942/0001564590-20-021942-index.htm
2020-08-0310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1435049/000156459020035508/0001564590-20-035508-index.htm
2020-08-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1435049/000156459020035522/0001564590-20-035522-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1435049/000156459020051403/0001564590-20-051403-index.htm
2018-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761918002681/0001567619-18-002681-index.htm
2018-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761918002682/0001567619-18-002682-index.htm
2018-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761918002683/0001567619-18-002683-index.htm
2018-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761918002684/0001567619-18-002684-index.htm
2018-09-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761918003109/0001567619-18-003109-index.htm
2018-09-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761918003110/0001567619-18-003110-index.htm
2018-11-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761918006813/0001567619-18-006813-index.htm
2018-12-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761918007494/0001567619-18-007494-index.htm
2018-12-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761918008011/0001567619-18-008011-index.htm
2018-12-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761918008013/0001567619-18-008013-index.htm
2018-12-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761918008014/0001567619-18-008014-index.htm
2018-12-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761918008015/0001567619-18-008015-index.htm
2018-12-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761918008822/0001567619-18-008822-index.htm
2019-02-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919002649/0001567619-19-002649-index.htm
2019-02-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919005094/0001567619-19-005094-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919005097/0001567619-19-005097-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919005099/0001567619-19-005099-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919005101/0001567619-19-005101-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919005105/0001567619-19-005105-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919005106/0001567619-19-005106-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919005107/0001567619-19-005107-index.htm
2019-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919005538/0001567619-19-005538-index.htm
2019-03-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919007394/0001567619-19-007394-index.htm
2019-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919008679/0001567619-19-008679-index.htm
2019-04-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919008984/0001567619-19-008984-index.htm
2019-04-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919008985/0001567619-19-008985-index.htm
2019-05-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919009775/0001567619-19-009775-index.htm
2019-05-083/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919010193/0001567619-19-010193-index.htm
2019-05-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919011350/0001567619-19-011350-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919011351/0001567619-19-011351-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919011352/0001567619-19-011352-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919011354/0001567619-19-011354-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919011355/0001567619-19-011355-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919011356/0001567619-19-011356-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919011358/0001567619-19-011358-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919011359/0001567619-19-011359-index.htm
2019-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919011878/0001567619-19-011878-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919014112/0001567619-19-014112-index.htm
2019-07-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919014788/0001567619-19-014788-index.htm
2019-07-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919014789/0001567619-19-014789-index.htm
2019-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919018455/0001567619-19-018455-index.htm
2019-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919018456/0001567619-19-018456-index.htm
2019-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919018457/0001567619-19-018457-index.htm
2019-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919018458/0001567619-19-018458-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919018506/0001567619-19-018506-index.htm
2019-12-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919023141/0001567619-19-023141-index.htm
2019-12-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919023142/0001567619-19-023142-index.htm
2019-12-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919023144/0001567619-19-023144-index.htm
2019-12-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761919023145/0001567619-19-023145-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761920000643/0001567619-20-000643-index.htm
2020-01-293Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761920001689/0001567619-20-001689-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761920004744/0001567619-20-004744-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761920004745/0001567619-20-004745-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761920004746/0001567619-20-004746-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761920004747/0001567619-20-004747-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761920004748/0001567619-20-004748-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761920004749/0001567619-20-004749-index.htm
2020-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761920004897/0001567619-20-004897-index.htm
2020-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761920006851/0001567619-20-006851-index.htm
2020-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761920006852/0001567619-20-006852-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761920011285/0001567619-20-011285-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761920011286/0001567619-20-011286-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761920011287/0001567619-20-011287-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761920011288/0001567619-20-011288-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761920011289/0001567619-20-011289-index.htm
2020-05-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761920011290/0001567619-20-011290-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761920011634/0001567619-20-011634-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761920011635/0001567619-20-011635-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761920011637/0001567619-20-011637-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761920011638/0001567619-20-011638-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761920011639/0001567619-20-011639-index.htm
2020-08-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761920014727/0001567619-20-014727-index.htm
2020-08-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761920014728/0001567619-20-014728-index.htm
2020-08-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761920014729/0001567619-20-014729-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761920016852/0001567619-20-016852-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761920016853/0001567619-20-016853-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1435049/000156761920016854/0001567619-20-016854-index.htm
2020-08-26EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1435049/999999999520002260/9999999995-20-002260-index.htm
2019-03-19CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1435049/999999999719001432/9999999997-19-001432-index.htm

Aduro Biotech, Inc (ADRO) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aduro Biotech, Inc (ADRO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 2984%
Institutional Ownership: 4476%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-06-01William G KachioffInterim CFOBuy10,000.0010,000.00https://www.sec.gov/Archives/edgar/data/1435049/000156761920011639/0001567619-20-011639-index.htm
2019-09-13Blaine TemplemanChief Legal OfficerSell5,888.001.317,689.14117,000.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919018455/0001567619-19-018455-index.htm
2019-12-12Blaine TemplemanChief Legal OfficerSell1,264.001.161,470.41117,736.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919023145/0001567619-19-023145-index.htm
2020-06-01Dimitry SA NuytenChief Medical OfficerBuy10,000.0012,000.00https://www.sec.gov/Archives/edgar/data/1435049/000156761920011635/0001567619-20-011635-index.htm
2020-06-01Ross HaghighatDirectorBuy34,124.00121,246.00https://www.sec.gov/Archives/edgar/data/1435049/000156761920011637/0001567619-20-011637-index.htm
2020-09-15Blaine TemplemanChief Legal OfficerSell12,369.002.3929,585.41121,916.00https://www.sec.gov/Archives/edgar/data/1435049/000156761920016853/0001567619-20-016853-index.htm
2019-09-13Blaine TemplemanChief Legal OfficerSell6,990.001.319,127.54122,888.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919018455/0001567619-19-018455-index.htm
2018-12-12Blaine TemplemanChief Legal OfficerSell1,241.002.933,638.61129,878.00https://www.sec.gov/Archives/edgar/data/1435049/000156761918008014/0001567619-18-008014-index.htm
2018-09-24Blaine TemplemanChief Legal OfficerSell10,262.005.8159,612.98131,119.00https://www.sec.gov/Archives/edgar/data/1435049/000156761918003109/0001567619-18-003109-index.htm
2018-11-20Blaine TemplemanChief Legal OfficerSell843.002.912,452.54131,119.00https://www.sec.gov/Archives/edgar/data/1435049/000156761918006813/0001567619-18-006813-index.htm
2020-08-07Blaine TemplemanChief Legal OfficerSell7,951.002.5520,307.65134,285.00https://www.sec.gov/Archives/edgar/data/1435049/000156761920014728/0001567619-20-014728-index.htm
2018-12-12Jennifer LewChief Financial OfficerSell1,035.002.933,034.62135,155.00https://www.sec.gov/Archives/edgar/data/1435049/000156761918008015/0001567619-18-008015-index.htm
2019-04-08Jennifer LewChief Financial OfficerSell2,232.004.079,087.14135,155.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919008679/0001567619-19-008679-index.htm
2019-04-08Jennifer LewChief Financial OfficerSell12,144.004.0749,468.58135,155.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919008679/0001567619-19-008679-index.htm
2019-04-08Jennifer LewChief Financial OfficerSell4,225.004.0817,219.41135,155.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919008679/0001567619-19-008679-index.htm
2019-05-01Jennifer LewChief Financial OfficerSell4,226.004.2017,750.89135,155.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919009775/0001567619-19-009775-index.htm
2018-09-13Jennifer LewChief Financial OfficerSell5,623.006.5036,545.56136,190.00https://www.sec.gov/Archives/edgar/data/1435049/000156761918002682/0001567619-18-002682-index.htm
2019-04-08Jennifer LewChief Financial OfficerBuy2,232.001.002,232.00137,387.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919008679/0001567619-19-008679-index.htm
2019-05-01Jennifer LewChief Financial OfficerBuy2,232.001.002,232.00137,387.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919009775/0001567619-19-009775-index.htm
2019-04-08Jennifer LewChief Financial OfficerBuy4,225.000.823,464.50139,380.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919008679/0001567619-19-008679-index.htm
2019-05-01Jennifer LewChief Financial OfficerBuy4,226.000.823,465.32139,381.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919009775/0001567619-19-009775-index.htm
2018-09-13Blaine TemplemanExecutive VP, General CounselSell6,056.006.5039,359.76141,381.00https://www.sec.gov/Archives/edgar/data/1435049/000156761918002684/0001567619-18-002684-index.htm
2018-09-12Jennifer LewChief Financial OfficerBuy67,825.00141,813.00https://www.sec.gov/Archives/edgar/data/1435049/000156761918002682/0001567619-18-002682-index.htm
2020-06-01Blaine TemplemanChief Legal OfficerBuy22,500.00142,236.00https://www.sec.gov/Archives/edgar/data/1435049/000156761920011634/0001567619-20-011634-index.htm
2019-04-08Jennifer LewChief Financial OfficerBuy12,144.001.4517,608.80147,299.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919008679/0001567619-19-008679-index.htm
2019-05-01Jennifer LewChief Financial OfficerBuy12,144.001.4517,608.80147,299.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919009775/0001567619-19-009775-index.htm
2018-09-12Blaine TemplemanExecutive VP, General CounselBuy77,500.00147,437.00https://www.sec.gov/Archives/edgar/data/1435049/000156761918002684/0001567619-18-002684-index.htm
2020-10-05Tom FrohlichChief Business OfficerBuy153,398.00153,398.00https://www.sec.gov/Archives/edgar/data/1435049/000120919120054246/0001209191-20-054246-index.htm
2018-09-13Natalie SacksChief Medical OfficerSell3,028.006.5019,679.88173,720.00https://www.sec.gov/Archives/edgar/data/1435049/000156761918002681/0001567619-18-002681-index.htm
2018-09-12Natalie SacksChief Medical OfficerBuy87,200.00176,748.00https://www.sec.gov/Archives/edgar/data/1435049/000156761918002681/0001567619-18-002681-index.htm
2020-03-18William Mariner GreenmanDirectorBuy19,835.000.458,925.7519,835.00https://www.sec.gov/Archives/edgar/data/1435049/000156761920006852/0001567619-20-006852-index.htm
2019-03-19Elsas Andrea vanChief Scientific OfficerSell6,081.003.9624,106.91239,557.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919007394/0001567619-19-007394-index.htm
2020-10-05Davis JerelDirectorBuy2,433,099.002,433,099.00https://www.sec.gov/Archives/edgar/data/1435049/000120919120054248/0001209191-20-054248-index.htm
2019-02-26Elsas Andrea vanChief Scientific OfficerSell6,844.004.2529,119.85245,638.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919005538/0001567619-19-005538-index.htm
2018-12-28Elsas Andrea vanChief Scientific OfficerSell1,907.002.574,900.99252,482.00https://www.sec.gov/Archives/edgar/data/1435049/000156761918008822/0001567619-18-008822-index.htm
2018-12-12Elsas Andrea vanChief Scientific OfficerSell2,171.002.936,365.37254,389.00https://www.sec.gov/Archives/edgar/data/1435049/000156761918008011/0001567619-18-008011-index.htm
2018-09-24Elsas Andrea vanChief Scientific OfficerSell7,726.005.8345,021.72256,560.00https://www.sec.gov/Archives/edgar/data/1435049/000156761918003110/0001567619-18-003110-index.htm
2018-09-13Elsas Andrea vanChief Scientific OfficerSell9,754.006.5063,394.17264,286.00https://www.sec.gov/Archives/edgar/data/1435049/000156761918002683/0001567619-18-002683-index.htm
2019-12-12Celeste FerberSVP, GC and SecretarySell408.001.16474.6326,534.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919023144/0001567619-19-023144-index.htm
2019-09-13Celeste FerberSVP, GC and SecretarySell1,102.001.311,439.3226,942.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919018458/0001567619-19-018458-index.htm
2018-09-12Elsas Andrea vanChief Scientific OfficerBuy67,825.00274,040.00https://www.sec.gov/Archives/edgar/data/1435049/000156761918002683/0001567619-18-002683-index.htm
2020-09-15STEPHEN T ISAACSPresident and CEOSell32,481.002.3977,691.30279,166.00https://www.sec.gov/Archives/edgar/data/1435049/000156761920016854/0001567619-20-016854-index.htm
2019-09-13Celeste FerberSVP, GC and SecretarySell1,392.001.311,817.8128,044.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919018458/0001567619-19-018458-index.htm
2019-12-12STEPHEN T ISAACSPresident and CEOSell5,897.001.166,859.98290,029.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919023141/0001567619-19-023141-index.htm
2019-05-20Celeste FerberSVP, GC and SecretarySell2,000.003.216,413.0029,436.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919011878/0001567619-19-011878-index.htm
2019-09-13STEPHEN T ISAACSPresident and CEOSell31,098.001.3140,607.77295,926.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919018457/0001567619-19-018457-index.htm
2020-03-18STEPHEN T ISAACSPresident and CEOSell21,618.000.459,728.10311,647.00https://www.sec.gov/Archives/edgar/data/1435049/000156761920006851/0001567619-20-006851-index.htm
2020-10-05SRINIVAS AKKARAJUDirectorBuy3,168,388.003,168,388.00https://www.sec.gov/Archives/edgar/data/1435049/000120919120054251/0001209191-20-054251-index.htm
2018-12-12STEPHEN T ISAACSPresident and CEOSell5,829.002.9317,090.63327,024.00https://www.sec.gov/Archives/edgar/data/1435049/000156761918008013/0001567619-18-008013-index.htm
2020-09-15Celeste FerberSVP, GC and SecretarySell2,396.002.395,730.9938,687.00https://www.sec.gov/Archives/edgar/data/1435049/000156761920016852/0001567619-20-016852-index.htm
2020-08-07Celeste FerberSVP, GC and SecretarySell7,951.002.5520,307.6541,083.00https://www.sec.gov/Archives/edgar/data/1435049/000156761920014727/0001567619-20-014727-index.htm
2020-02-25Elsas Andrea vanChief Scientific OfficerSell6,823.003.5123,953.51438,367.00https://www.sec.gov/Archives/edgar/data/1435049/000156761920004897/0001567619-20-004897-index.htm
2020-01-03Elsas Andrea vanChief Scientific OfficerSell73,311.001.1987,108.13445,190.00https://www.sec.gov/Archives/edgar/data/1435049/000156761920000643/0001567619-20-000643-index.htm
2020-10-05ERIC DOBMEIERPresident, CEOBuy46,337.0046,337.00https://www.sec.gov/Archives/edgar/data/1435049/000120919120054245/0001209191-20-054245-index.htm
2020-10-05Davis JerelDirectorBuy4,733,023.004,733,023.00https://www.sec.gov/Archives/edgar/data/1435049/000120919120054248/0001209191-20-054248-index.htm
2020-06-01Celeste FerberSVP, GC and SecretaryBuy22,500.0049,034.00https://www.sec.gov/Archives/edgar/data/1435049/000156761920011638/0001567619-20-011638-index.htm
2019-09-16Ross HaghighatDirectorBuy18,000.001.0018,000.0049,583.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919018506/0001567619-19-018506-index.htm
2019-12-12Elsas Andrea vanChief Scientific OfficerSell2,192.001.162,549.95518,501.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919023142/0001567619-19-023142-index.htm
2019-09-13Elsas Andrea vanChief Scientific OfficerSell634.001.31828.07520,693.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919018456/0001567619-19-018456-index.htm
2019-09-13Elsas Andrea vanChief Scientific OfficerSell17,959.001.3123,450.86521,327.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919018456/0001567619-19-018456-index.htm
2019-06-26Elsas Andrea vanChief Scientific OfficerBuy275,000.00539,286.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919014112/0001567619-19-014112-index.htm
2019-09-16Ross HaghighatDirectorBuy21,451.000.459,652.9571,034.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919018506/0001567619-19-018506-index.htm
2020-10-05Davis JerelDirectorBuy722,247.00722,247.00https://www.sec.gov/Archives/edgar/data/1435049/000120919120054248/0001209191-20-054248-index.htm
2020-10-05Davis JerelDirectorBuy730,470.00730,470.00https://www.sec.gov/Archives/edgar/data/1435049/000120919120054248/0001209191-20-054248-index.htm
2019-09-16Ross HaghighatDirectorBuy4,566.000.452,054.7075,600.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919018506/0001567619-19-018506-index.htm
2019-09-16Ross HaghighatDirectorBuy2,459.000.451,106.5578,059.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919018506/0001567619-19-018506-index.htm
2020-08-07Dimitry SA NuytenChief Medical OfficerSell3,538.002.559,036.418,462.00https://www.sec.gov/Archives/edgar/data/1435049/000156761920014729/0001567619-20-014729-index.htm
2019-09-16Ross HaghighatDirectorBuy9,063.000.524,712.7687,122.00https://www.sec.gov/Archives/edgar/data/1435049/000156761919018506/0001567619-19-018506-index.htm